Medtronic (2M6) Stock Statistics & Valuation Metrics

Medtronic has a market cap or net worth of €90.98B. The enterprise value is €127.25B.

Medtronic has 1,280,045,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medtronic’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.13%.

The current PE Ratio of Medtronic is 21.6. Medtronic’s PEG ratio is 6.72.

In the last 12 months, Medtronic had revenue of 36.36B and earned 4.80B in profits. Earnings per share was 3.75.

In the last 12 months, operating cash flow was 9.86B and capital expenditures -2.36B, giving a free cash flow of 7.50B billion.

Medtronic pays an annual dividend of €0.632, resulting in a dividend yield of 3.01%

Medtronic upcoming earnings date is Aug 25, 2026, Before Open (Confirmed).

Medtronic as a current ratio of 2.13, with Debt / Equity ratio of 56.53%

In the past 12 months, Medtronic has paid 1.30B in taxes.

Medtronic EV to EBITDA ratio is 13.54, with an EV/FCF ratio of 24.48.

Medtronic has €9.22B in cash and marketable securities with €27.96B in debt, giving a net cash position of -€18.74B billion.

Gross margin is 65.02%, with operating margin of 17.78%, and net profit margin of 13.20%.

The average price target for Medtronic is €86.20, which is 11.43% higher than the current price. The consensus rating is Moderate Buy